Skip to main content
Livermore
Livermore
ZHEN

Payden & Rygel

SEC CIK
0000919219
Latest filing
Jul 31, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
73,250
Value
$18.4M
% of portfolio
1.4%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Payden & Rygel, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202673,250$18.4M1.4%+520+0.7%AddedHolders
Q1 202672,730$15.8M1.2%+15,720+27.6%AddedHolders
Q4 202557,010$13.0M0.9%−400−0.7%ReducedHolders
Q3 202557,410$13.3M1.1%+57,300+52,090.9%AddedHolders
Q2 2025110$20.0K<0.1%−50,900−99.8%ReducedHolders
Q1 202551,010$10.7M0.9%+50,900+46,272.7%AddedHolders
Q4 2024110$20.0K<0.1%−4,900−97.8%ReducedHolders
Q3 20245,010$989.0K0.1%00.0%UnchangedHolders
Q2 20245,010$859.0K0.1%00.0%UnchangedHolders
Q1 20245,010$912.0K0.1%00.0%UnchangedHolders
Q4 20235,010$776.0K0.1%00.0%UnchangedHolders
Q3 20235,010$747.0K0.1%−117,730−95.9%ReducedHolders
Q2 2023122,740$16.5M1.2%−25,600−17.3%ReducedHolders
Q1 2023148,340$23.6M1.4%−59,930−28.8%ReducedHolders
Q4 2022208,270$33.7M1.8%−42,800−17.0%ReducedHolders
Q3 2022251,070$33.7M2.0%+4,500+1.8%AddedHolders
Q2 2022246,570$37.8M2.3%+33,700+15.8%AddedHolders
Q1 2022212,870$34.5M1.7%−137,540−39.3%ReducedHolders
Q4 2021350,410$47.4M2.2%+69,460+24.7%AddedHolders
Q3 2021280,950$30.3M1.6%+89,150+46.5%AddedHolders
Q2 2021191,800$21.6M1.0%−33,400−14.8%ReducedHolders
Q1 2021225,200$24.4M1.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.